Ian Pagano to Quality of Life
This is a "connection" page, showing publications Ian Pagano has written about Quality of Life.
Connection Strength
1.395
-
Gotay CC, Ransom S, Pagano IS. Quality of life in survivors of multiple primary cancers compared with cancer survivor controls. Cancer. 2007 Nov 01; 110(9):2101-9.
Score: 0.235
-
Gotay CC, Pagano IS. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007 Mar 13; 5:15.
Score: 0.225
-
Pagano IS, Gotay CC. Ethnic differential item functioning in the assessment of quality of life in cancer patients. Health Qual Life Outcomes. 2005 Oct 07; 3:60.
Score: 0.204
-
Gotay CC, Isaacs P, Pagano I. Quality of life in patients who survive a dire prognosis compared to control cancer survivors. Psychooncology. 2004 Dec; 13(12):882-92.
Score: 0.192
-
Gotay CC, Blaine D, Haynes SN, Holup J, Pagano IS. Assessment of quality of life in a multicultural cancer patient population. Psychol Assess. 2002 Dec; 14(4):439-50.
Score: 0.167
-
Gotay CC, Holup JL, Pagano I. Ethnic differences in quality of life among early breast and prostate cancer survivors. Psychooncology. 2002 Mar-Apr; 11(2):103-13.
Score: 0.159
-
Okado I, Pagano I, Cassel K, Holcombe RF. Perceptions of care coordination in cancer patient-family caregiver dyads. Support Care Cancer. 2021 May; 29(5):2645-2652.
Score: 0.144
-
Loo LWM, Nishibun K, Welsh L, Makolo T, Chong CD, Pagano I, Yu H, Bantum EO. Using a cultural dance program to increase sustainable physical activity for breast cancer survivors-A pilot study. Complement Ther Med. 2019 Dec; 47:102197.
Score: 0.033
-
Matsuno RK, Pagano IS, Maskarinec G, Issell BF, Gotay CC. Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors. J Womens Health (Larchmt). 2012 Dec; 21(12):1252-8.
Score: 0.021
-
Issell BF, Gotay CC, Pagano I, Franke AA. Using quality of life measures in a Phase I clinical trial of noni in patients with advanced cancer to select a Phase II dose. J Diet Suppl. 2009; 6(4):347-59.
Score: 0.016